Overcoming Multistep Biological Barriers Restores CD8⁺ T Cell Infiltration in Tumors
A comprehensive review identifies the biological checkpoints and physical barriers regulating CD8⁺ T cell infiltration in cancer and outlines sequential ...
A comprehensive review identifies the biological checkpoints and physical barriers regulating CD8⁺ T cell infiltration in cancer and outlines sequential ...
A Phase 1 trial demonstrates that the selective GLS1 inhibitor IACS-6274 combined with paclitaxel and bevacizumab achieved tumor shrinkage in ...
In a phase I trial of fourteen patients with advanced ovarian cancer, the investigational glutaminase-1 inhibitor IACS-6274 combined with bevacizumab ...
A review indicates that vascular endothelial dysfunction and blood pressure elevation jointly contribute to proteinuria during VEGF inhibitor cancer therapy.
A case report details how a patient with recurrent ovarian cancer developed early-onset duodenal perforation during bevacizumab chemotherapy amid concurrent ...
A large retrospective study in Japan found no significant difference in venous thromboembolism risk between cancer patients receiving a bevacizumab ...
A case report describes recurrent intraocular inflammation following faricimab and aflibercept 8 mg despite prior uneventful tolerance of lower and ...
A retrospective cohort study found that concomitant SGLT2 inhibitor use was associated with a significantly lower incidence of grade 2 ...
Preclinical glioblastoma models reveal that tumors evade anti-VEGF therapy by activating a transient neuronal-like remodeling program driven by the CTNNB1–NRG3–ERBB4 ...
A retrospective study reveals frequent local progression and identifies tumor volume as a significant risk factor following CyberKnife radiosurgery for ...
Triple-negative breast cancer, defined by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression, ...
A clinical case report demonstrates that combining trifluridine/tipiracil plus bevacizumab with stereotactic radiofrequency ablation produced thirty-four months of overall survival ...
A narrative review evaluates trial evidence indicating that KELIM chemosensitivity scores, rather than BRCA or homologous recombination deficiency status, predict ...
A case report documents the regression of presumed brain metastases and 15-month survival in a 51-year-old cervical cancer patient treated ...
A comprehensive genomic review reveals how cancer stem cells, viral integration, and clonal signaling pathways drive hepatocellular carcinoma, highlighting emerging ...
A narrative review outlines a cardio-neuro-oncology framework to address cardiovascular toxicities and overlapping clinical complications across contemporary central nervous system ...
A single-center retrospective study linked multi-target TKIs plus immunotherapy to longer survival than bevacizumab regimens in advanced hepatocellular carcinoma.
A study in BMC Gastroenterology indicates that FGL1 regulates hepatocellular carcinoma cell proliferation and apoptosis partially through the PI3K/AKT/mTOR signaling ...
Clinicians have identified a rare germline LZTR1 frameshift mutation accompanied by loss of heterozygosity and homologous recombination deficiency in a ...
A retrospective study shows that quantified baseline ascites volume above 613.5 milliliters independently predicts significantly reduced survival in patients receiving ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.